A robotic exoskeleton for the treatment of crouch (or flexed-knee) gait in children with cerebral palsy has been developed by US researchers from the Rehabilitation Medicine department of the NIH Clinical Centre.
MedGenomeGenomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
Chiesi's Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.
A "body-on-a-chip" device that can evaluate the side-effects of drugs on human cells has been developed by researchers at Kyoto University's Institute for Integrated Cell-Material Sciences, according to a study published today in the Royal Society of Chemistry Advances.
Collaboration on an oncology drug discovery program was inked between Takeda Pharmaceutical, through its subsidiary Millennium Pharmaceuticals, and Molecular Templates.
Siemens Healthineers has received CE-Mark for its ultra-high-field 7T magnetic resonance (MR) scanner Magnetom Terra, making it available for neurological and musculoskeletal clinical examinations in Europe.
A five-year strategic research collaboration between AstraZeneca and its global biologics research and development arm MedImmune and Ethris, a company focussed on mRNA-based therapeutics with specific expertise in pulmonary disease.
A new nerve-illuminating tool has been developed by researchers and they claim it makes nerves stand out from other tissue, lighting it up to help surgeons avoid accidentally injuring nerves and identify nerves in need of repair.
New treatments for neurodegenerative disease and motion disability will be developed by a research collaboration between digital healthcare solutions provider MC10 and US-based rehabilitation research hospital, Shirley Ryan AbilityLab.
Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.